Lazard Capital Starts Supernus Pharmaceuticals (SUPN) at Buy
Tweet Send to a Friend
Lazard Capital initiates coverage on Supernus Pharmaceuticals (NASDAQ: SUPN) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
